← board
ENSCW
distress 6/10 · elevated risk$0.02today0% from 52w high
Revenue
pre-revenue
Liquidity
$1M
Runway
0.1 yrs
Shares 1y
+395%
Overview
- Market Cap
- $293.89K
- Volume
- 42.20K
- 52 Week Range
- $0.02 – $0.02
- Total Shares
- 14.69M
- Float Shares
- 14.68M
- RVOL
- 1.00x
- Beta
- 0.82
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 14,694,492 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.